BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 25984394)

  • 1. Network-Based Identification of Smoking-Associated Gene Signature for Lung Cancer.
    Wan YW; Xiao C; Guo NL
    Proceedings (IEEE Int Conf Bioinformatics Biomed); 2010 Dec; 2010():479-484. PubMed ID: 25984394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathway-based identification of a smoking associated 6-gene signature predictive of lung cancer risk and survival.
    Guo NL; Wan YW
    Artif Intell Med; 2012 Jun; 55(2):97-105. PubMed ID: 22326768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Novel Network Model for Molecular Prognosis.
    Wan YW; Bose S; Denvir J; Guo NL
    ACM Int Conf Bioinform Comput Biol (2010); 2010; 2010():342-345. PubMed ID: 26005718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A gene-signature progression approach to identifying candidate small-molecule cancer therapeutics with connectivity mapping.
    Wen Q; Kim CS; Hamilton PW; Zhang SD
    BMC Bioinformatics; 2016 May; 17(1):211. PubMed ID: 27170106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A robust six-gene prognostic signature for prediction of both disease-free and overall survival in non-small cell lung cancer.
    Zuo S; Wei M; Zhang H; Chen A; Wu J; Wei J; Dong J
    J Transl Med; 2019 May; 17(1):152. PubMed ID: 31088477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Establishment of a 12-gene expression signature to predict colon cancer prognosis.
    Sun D; Chen J; Liu L; Zhao G; Dong P; Wu B; Wang J; Dong L
    PeerJ; 2018; 6():e4942. PubMed ID: 29915691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A four-gene signature from NCI-60 cell line for survival prediction in non-small cell lung cancer.
    Hsu YC; Yuan S; Chen HY; Yu SL; Liu CH; Hsu PY; Wu G; Lin CH; Chang GC; Li KC; Yang PC
    Clin Cancer Res; 2009 Dec; 15(23):7309-15. PubMed ID: 19920108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Robust 8-Gene Prognostic Signature for Early-Stage Non-small Cell Lung Cancer.
    He R; Zuo S
    Front Oncol; 2019; 9():693. PubMed ID: 31417870
    [No Abstract]   [Full Text] [Related]  

  • 9. Serum Metabolic Profiling Identified a Distinct Metabolic Signature in Bladder Cancer Smokers: A Key Metabolic Enzyme Associated with Patient Survival.
    Amara CS; Ambati CR; Vantaku V; Badrajee Piyarathna DW; Donepudi SR; Ravi SS; Arnold JM; Putluri V; Chatta G; Guru KA; Badr H; Terris MK; Bollag RJ; Sreekumar A; Apolo AB; Putluri N
    Cancer Epidemiol Biomarkers Prev; 2019 Apr; 28(4):770-781. PubMed ID: 30642841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RNA-seq analysis of lung adenocarcinomas reveals different gene expression profiles between smoking and nonsmoking patients.
    Li Y; Xiao X; Ji X; Liu B; Amos CI
    Tumour Biol; 2015 Nov; 36(11):8993-9003. PubMed ID: 26081616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular signature of smoking in human lung tissues.
    Bossé Y; Postma DS; Sin DD; Lamontagne M; Couture C; Gaudreault N; Joubert P; Wong V; Elliott M; van den Berge M; Brandsma CA; Tribouley C; Malkov V; Tsou JA; Opiteck GJ; Hogg JC; Sandford AJ; Timens W; Paré PD; Laviolette M
    Cancer Res; 2012 Aug; 72(15):3753-63. PubMed ID: 22659451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Smoking and cancer-related gene expression in bronchial epithelium and non-small-cell lung cancers.
    Woenckhaus M; Klein-Hitpass L; Grepmeier U; Merk J; Pfeifer M; Wild P; Bettstetter M; Wuensch P; Blaszyk H; Hartmann A; Hofstaedter F; Dietmaier W
    J Pathol; 2006 Oct; 210(2):192-204. PubMed ID: 16915569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved survival in never-smokers vs current smokers with primary adenocarcinoma of the lung.
    Nordquist LT; Simon GR; Cantor A; Alberts WM; Bepler G
    Chest; 2004 Aug; 126(2):347-51. PubMed ID: 15302716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A specific gene expression signature for visceral organ metastasis in breast cancer.
    Savci-Heijink CD; Halfwerk H; Koster J; Horlings HM; van de Vijver MJ
    BMC Cancer; 2019 Apr; 19(1):333. PubMed ID: 30961553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identifying a new microRNA signature as a prognostic biomarker in colon cancer.
    Lv Y; Duanmu J; Fu X; Li T; Jiang Q
    PLoS One; 2020; 15(2):e0228575. PubMed ID: 32049961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential impact of CX3CL1 on lung cancer prognosis in smokers and non-smokers.
    Su YC; Chang H; Sun SJ; Liao CY; Wang LY; Ko JL; Chang JT
    Mol Carcinog; 2018 May; 57(5):629-639. PubMed ID: 29380447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a five-gene signature with prognostic value in colorectal cancer.
    Sun G; Li Y; Peng Y; Lu D; Zhang F; Cui X; Zhang Q; Li Z
    J Cell Physiol; 2019 Apr; 234(4):3829-3836. PubMed ID: 30132881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrative Bioinformatics Analysis Reveals Potential Long Non-Coding RNA Biomarkers and Analysis of Function in Non-Smoking Females with Lung Cancer.
    Qiao F; Li N; Li W
    Med Sci Monit; 2018 Aug; 24():5771-5778. PubMed ID: 30120911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pancreatic cancer survival analysis defines a signature that predicts outcome.
    Raman P; Maddipati R; Lim KH; Tozeren A
    PLoS One; 2018; 13(8):e0201751. PubMed ID: 30092011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel risk score system for assessment of ovarian cancer based on co-expression network analysis and expression level of five lncRNAs.
    Zhao Q; Fan C
    BMC Med Genet; 2019 Jun; 20(1):103. PubMed ID: 31182053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.